drugset / Trial / NCT02327546
Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548
RandomizedCrossoverOpen-labelOther
Summary
The primary purpose of this study is to assess the single-dose bioavailability of AKB-6548 with ferrous sulfate relative to AKB-6548 in healthy volunteers.
Timeline
- Start
- 2014-12
- Primary completion
- 2014-12
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 325 mg | — |
| Subject | Vadadustat | Small molecule | 450 mg | — |
Indications
No indication recorded.